Lite Strategy, Inc.
LITS
$0.75
-$0.01-1.10%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/19/2026
-
Simply Wall St
5/14/2026
-
The Cerbat Gem
5/13/2026
-
Globe Newswire
2/17/2026
-
The Fly
2/17/2026
-
TipRanks Financial Blog
2/17/2026
-
The Fly
2/17/2026
-
The Fly
2/17/2026
-
Globe Newswire
2/15/2026
-
Ticker Report
2/12/2026
-
TipRanks Financial Blog
1/14/2026
-
MarketBeat
12/24/2025
-
Simply Wall St
12/23/2025
-
MarketBeat
12/22/2025
-
Ticker Report
12/22/2025
-
MarketBeat
12/22/2025
-
MarketBeat
12/22/2025
-
GuruFocus
11/23/2025
-
MarketBeat
11/20/2025
-
GuruFocus
11/19/2025
-
GuruFocus
11/19/2025
-
TipRanks Financial Blog
11/19/2025
-
The Fly
11/18/2025
-
TipRanks Financial Blog
11/17/2025
-
TipRanks Financial Blog
11/17/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, May 13, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Sep 21 and 25 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
858 369 7100
Address
9920 Pacific Heights Blvd.
San Diego, CA 92121
San Diego, CA 92121
Country
Year Founded
Business Description
Sector
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI...
more